利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

66 条记录 (耗时 0.022 秒)

    Polyorganosiloxane composition, cured product of the composition, and method for producing the composition
    4.
    发明授权
    Polyorganosiloxane composition, cured product of the composition, and method for producing the composition 失效
    聚有机硅氧烷组合物，组合物的固化产物，以及组合物的制造方法

    公开(公告)号：US08440848B2

    公开(公告)日：2013-05-14

    申请号：US13128509

    申请日：2009-11-06

    申请人： Yasushi Murakami ,  Masami Kobayashi ,  Takuya Kawashima ,  Wataru Shimizu ,  Shuhei Nakamura

    发明人： Yasushi Murakami ,  Masami Kobayashi ,  Takuya Kawashima ,  Wataru Shimizu ,  Shuhei Nakamura

    IPC分类号： C07F7/08 ,  C07F7/02

    CPC分类号： C08G77/398 ,  C08G77/16 ,  C08G77/58 ,  C08K5/057 ,  C08L83/04 ,  C08L83/14 ,  C08L83/06

    摘要： Disclosed is an organosiloxane composition which can be produced at low cost and is usable for bonding of glasses, metals and resins. The organosiloxane composition can provide a cured product exhibiting excellent heat resistance and cold resistance, while having high strength and high transparency. Specifically disclosed is a polyorganosiloxane composition containing (A) a polyorganosiloxane wherein at least one end of each molecule is modified with a silanol group, and (B) 0.5-4.0 moles of a metal alkoxide per 1 mole of the polyorganosiloxane, wherein the mean molecular weight (Mw) of the polyorganosiloxane according to the mass fraction is not more than 1,000. Also specifically disclosed are a cured product of the composition and a method for producing the composition.

    摘要翻译： 公开了可以低成本制造并且可用于玻璃，金属和树脂的结合的有机硅氧烷组合物。 有机硅氧烷组合物可以提供具有优异的耐热性和耐寒性的固化产品，同时具有高强度和高透明度。 具体公开了含有（A）聚有机硅氧烷的聚有机硅氧烷组合物，其中每个分子的至少一个末端用硅烷醇基改性，和（B）每1摩尔聚有机硅氧烷0.5-4.0摩尔金属醇盐，其中平均分子量 聚有机硅氧烷的质量分数的重量（Mw）不大于1,000。 还具体公开了组合物的固化产物和该组合物的制造方法。

    Lens-interchangeable camera performing focus control, lens barrel, and program
    5.
    发明授权
    Lens-interchangeable camera performing focus control, lens barrel, and program 有权
    透镜可互换的相机执行对焦控制，镜筒和程序

    公开(公告)号：US08355626B2

    公开(公告)日：2013-01-15

    申请号：US13109378

    申请日：2011-05-17

    申请人： Masanori Ishikawa ,  Masahisa Tamura ,  Tadanori Okada ,  Takumi Yamanaka ,  Kunihiko Sasaki ,  Yasushi Murakami ,  Shota Shimada ,  Takeya Nakayama

    发明人： Masanori Ishikawa ,  Masahisa Tamura ,  Tadanori Okada ,  Takumi Yamanaka ,  Kunihiko Sasaki ,  Yasushi Murakami ,  Shota Shimada ,  Takeya Nakayama

    IPC分类号： G03B13/22

    CPC分类号： G03B13/36 ,  H04N5/23209 ,  H04N5/23212

    摘要： A lens-interchangeable camera includes a focus detector performing focus detection and a controller performing a drive control of a lens based on a defocus amount. The controller finishes focusing operation without driving the lens when the defocus amount is out a range of a first in-focus determination width, and performs the focusing operation when the defocus amount is out a range of the first in-focus determination width. The controller finishes the focusing operation without performing the focus detection again after completing the drive when the defocus amount is out a range of a second in-focus determination width, and performs the focus detection again after completing the drive when the defocus amount is out a range of the second in-focus determination width. The second in-focus determination width is set to be greater than the first in-focus determination width and be greater than or equal to a drive limit value.

    摘要翻译： 可透镜相机包括执行焦点检测的焦点检测器和基于散焦量执行透镜的驱动控制的控制器。 当散焦量超出第一对焦确定宽度的范围时，控制器完成聚焦操作而不驱动透镜，并且当散焦量在第一对焦确定宽度的范围之外时，执行聚焦操作。 当散焦量在第二对焦确定宽度的范围之外时，在完成驱动之后，控制器完成聚焦操作，而不执行聚焦检测，并且当散焦量为零时完成驱动后再次进行焦点检测 第二对焦确定宽度的范围。 第二对焦确定宽度被设置为大于第一对焦确定宽度并且大于或等于驱动极限值。

    Pharmaceutical composition
    6.
    发明授权
    Pharmaceutical composition 有权
    药物组成

    公开(公告)号：US08202898B1

    公开(公告)日：2012-06-19

    申请号：US13365785

    申请日：2012-02-03

    申请人： Yasushi Murakami ,  Naoko Kobayashi ,  Azuma Nishio ,  Nobuo Kubota

    发明人： Yasushi Murakami ,  Naoko Kobayashi ,  Azuma Nishio ,  Nobuo Kubota

    IPC分类号： A01N43/52 ,  A61K31/415 ,  C07D233/28 ,  C07D233/91

    CPC分类号： A61K9/08 ,  A61K9/0019 ,  A61K31/4168 ,  A61K41/0038 ,  C07D233/91

    摘要： To provide a pharmaceutical composition containing a 2-nitroimidazole derivative, which has high solubility in an aqueous carrier and high stability.The pharmaceutical composition is characterized by containing 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole and creatinine, and containing creatinine of 0.001 to 1 part by mass with respect to 1 part by mass of 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole.

    摘要翻译： 提供含有在水性载体中具有高溶解度和高稳定性的2-硝基咪唑衍生物的药物组合物。 该药物组合物的特征在于含有1-（1-羟甲基-2,3-二羟丙基）氧甲基-2-硝基咪唑和肌酸酐，相对于1质量份的1-（1 - 羟基甲基-2,3-二羟丙基）氧基甲基-2-硝基咪唑。

    LENS-INTERCHANGEABLE CAMERA PERFORMING FOCUS CONTROL, LENS BARREL, AND PROGRAM
    8.
    发明申请
    LENS-INTERCHANGEABLE CAMERA PERFORMING FOCUS CONTROL, LENS BARREL, AND PROGRAM 有权
    镜头可互换摄像机执行焦点控制，镜头条和程序

    公开(公告)号：US20110286733A1

    公开(公告)日：2011-11-24

    申请号：US13109378

    申请日：2011-05-17

    申请人： Masanori Ishikawa ,  Masahisa Tamura ,  Tadanori Okada ,  Takumi Yamanaka ,  Kunihiko Sasaki ,  Yasushi Murakami ,  Shota Shimada ,  Takeya Nakayama

    发明人： Masanori Ishikawa ,  Masahisa Tamura ,  Tadanori Okada ,  Takumi Yamanaka ,  Kunihiko Sasaki ,  Yasushi Murakami ,  Shota Shimada ,  Takeya Nakayama

    IPC分类号： G03B13/34

    CPC分类号： G03B13/36 ,  H04N5/23209 ,  H04N5/23212

    摘要： A lens-interchangeable camera includes a focus detector performing focus detection and a controller performing a drive control of a lens based on a defocus amount. The controller finishes focusing operation without driving the lens when the defocus amount is out a range of a first in-focus determination width, and performs the focusing operation when the defocus amount is out a range of the first in-focus determination width. The controller finishes the focusing operation without performing the focus detection again after completing the drive when the defocus amount is out a range of a second in-focus determination width, and performs the focus detection again after completing the drive when the defocus amount is out a range of the second in-focus determination width. The second in-focus determination width is set to be greater than the first in-focus determination width and be greater than or equal to a drive limit value.

    摘要翻译： 可透镜相机包括执行焦点检测的焦点检测器和基于散焦量执行透镜的驱动控制的控制器。 当散焦量超出第一对焦确定宽度的范围时，控制器完成聚焦操作而不驱动透镜，并且当散焦量在第一对焦确定宽度的范围之外时，执行聚焦操作。 当散焦量在第二对焦确定宽度的范围之外时，在完成驱动之后，控制器完成聚焦操作，而不执行聚焦检测，并且当散焦量为零时完成驱动后再次进行焦点检测 第二对焦确定宽度的范围。 第二对焦确定宽度被设置为大于第一对焦确定宽度并且大于或等于驱动极限值。

    PHARMACEUTICAL COMPOSITION
    9.
    发明申请
    PHARMACEUTICAL COMPOSITION 有权
    药物组合物

    公开(公告)号：US20100130576A1

    公开(公告)日：2010-05-27

    申请号：US12598044

    申请日：2008-04-16

    申请人： Yasushi Murakami ,  Naoko Kobayashi ,  Azuma Nishio ,  Nobuo Kubota

    发明人： Yasushi Murakami ,  Naoko Kobayashi ,  Azuma Nishio ,  Nobuo Kubota

    IPC分类号： A61K31/4168 ,  A61P35/00

    CPC分类号： A61K9/08 ,  A61K9/0019 ,  A61K31/4168 ,  A61K41/0038 ,  C07D233/91

    摘要： To provide a pharmaceutical composition containing a 2-nitroimidazole derivative, which has high solubility in an aqueous carrier and high stability.The pharmaceutical composition is characterized by containing 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole and creatinine, and containing creatinine of 0.001 to 1 part by mass with respect to 1 part by mass of 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole.

    摘要翻译： 提供含有在水性载体中具有高溶解度和高稳定性的2-硝基咪唑衍生物的药物组合物。 该药物组合物的特征在于含有1-（1-羟甲基-2,3-二羟丙基）氧甲基-2-硝基咪唑和肌酸酐，相对于1质量份的1-（1 - 羟基甲基-2,3-二羟丙基）氧基甲基-2-硝基咪唑。

    PHARMACEUTICAL COMPOSITION
    10.
    发明申请
    PHARMACEUTICAL COMPOSITION 有权
    药物组合物

    公开(公告)号：US20100076042A1

    公开(公告)日：2010-03-25

    申请号：US12523067

    申请日：2008-01-17

    申请人： Yasushi Murakami ,  Naoko Kobayashi ,  Azuma Nishio ,  Nobuo Kubota

    发明人： Yasushi Murakami ,  Naoko Kobayashi ,  Azuma Nishio ,  Nobuo Kubota

    IPC分类号： A61K31/417 ,  A61P35/00

    CPC分类号： A61K31/4168 ,  A61K9/0019 ,  A61K47/12 ,  A61K47/18 ,  A61K47/22

    摘要： To provide a pharmaceutical composition which can enhance the storage stability of 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole without impairing the effect of the compound.The pharmaceutical composition includes 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole, which is represented by formula (1): and a compound having chelating ability.

    摘要翻译： 提供能够提高1-（1-羟甲基-2,3-二羟基丙氧基甲基）-2-硝基咪唑的保存稳定性的药物组合物，而不损害化合物的作用。 药物组合物包括由式（1）表示的1-（1-羟甲基-2,3-二羟基丙氧基甲基）-2-硝基咪唑：和具有螯合能力的化合物。